TY - JOUR AU - Tandle, A. AU - Hanna, E. AU - Lorang, D. AU - Hajitou, A. AU - Moya, C. A. AU - Pasqualini, R. PY - 2009 DA - 2009// TI - Tumor vasculature-targeted delivery of tumor necrosis factor-alpha JO - Cancer VL - 115 UR - https://doi.org/10.1002/cncr.24001 DO - 10.1002/cncr.24001 ID - Tandle2009 ER - TY - JOUR AU - Curnis, F. AU - Sacchi, A. AU - Borgna, L. AU - Magni, F. AU - Gasparri, A. AU - Corti, A. PY - 2000 DA - 2000// TI - Enhancement of tumor necrosis factor alpha antitumor immunotherapeutic properties by targeted delivery to aminopeptidase N (CD13) JO - Nat Biotechnol VL - 18 UR - https://doi.org/10.1038/81183 DO - 10.1038/81183 ID - Curnis2000 ER - TY - JOUR AU - Lejeune, F. J. AU - Lienard, D. AU - Matter, M. AU - Ruegg, C. PY - 2006 DA - 2006// TI - Efficiency of recombinant human TNF in human cancer therapy JO - Cancer Immun VL - 6 ID - Lejeune2006 ER - TY - JOUR AU - Lejeune, F. J. AU - Ruegg, C. PY - 2006 DA - 2006// TI - Recombinant human tumor necrosis factor: an efficient agent for cancer treatment JO - Bull Cancer VL - 93 ID - Lejeune2006 ER - TY - JOUR AU - Mortara, L. AU - Balza, E. AU - Sassi, F. AU - Castellani, P. AU - Carnemolla, B. AU - Lerma, B. a. r. b. a. r. o. A. PY - 2007 DA - 2007// TI - Therapy-induced antitumor vaccination by targeting tumor necrosis factor alpha to tumor vessels in combination with melphalan JO - Eur J Immunol VL - 37 UR - https://doi.org/10.1002/eji.200737450 DO - 10.1002/eji.200737450 ID - Mortara2007 ER - TY - JOUR AU - Curnis, F. AU - Gasparri, A. AU - Sacchi, A. AU - Longhi, R. AU - Corti, A. PY - 2004 DA - 2004// TI - Coupling tumor necrosis factor-alpha with alphaV integrin ligands improves its antineoplastic activity JO - Cancer Res VL - 64 UR - https://doi.org/10.1158/0008-5472.CAN-03-1753 DO - 10.1158/0008-5472.CAN-03-1753 ID - Curnis2004 ER - TY - JOUR AU - Schiller, J. H. AU - Storer, B. E. AU - Witt, P. L. AU - Alberti, D. AU - Tombes, M. B. AU - Arzoomanian, R. PY - 1991 DA - 1991// TI - Biological and clinical effects of intravenous tumor necrosis factor-alpha administered three times weekly JO - Cancer Res VL - 51 ID - Schiller1991 ER - TY - JOUR AU - Eggermont, A. M. AU - Wilt, J. H. AU - Hagen, T. L. PY - 2003 DA - 2003// TI - Current uses of isolated limb perfusion in the clinic and a model system for new strategies JO - Lancet Oncol VL - 4 UR - https://doi.org/10.1016/S1470-2045(03)01141-0 DO - 10.1016/S1470-2045(03)01141-0 ID - Eggermont2003 ER - TY - JOUR AU - Hayes, A. J. AU - Neuhaus, S. J. AU - Clark, M. A. AU - Thomas, J. M. PY - 2007 DA - 2007// TI - Isolated limb perfusion with melphalan and tumor necrosis factor alpha for advanced melanoma and soft-tissue sarcoma JO - Ann Surg Oncol VL - 14 UR - https://doi.org/10.1245/s10434-006-9040-x DO - 10.1245/s10434-006-9040-x ID - Hayes2007 ER - TY - JOUR AU - Dondossola, E. AU - Gasparri, A. M. AU - Colombo, B. AU - Sacchi, A. AU - Curnis, F. AU - Corti, A. PY - 2011 DA - 2011// TI - Chromogranin A restricts drug penetration and limits the ability of NGR-TNF to enhance chemotherapeutic efficacy JO - Cancer Res VL - 71 UR - https://doi.org/10.1158/0008-5472.CAN-11-1273 DO - 10.1158/0008-5472.CAN-11-1273 ID - Dondossola2011 ER - TY - JOUR AU - Bertilaccio, M. T. AU - Grioni, M. AU - Sutherland, B. W. AU - Degl’Innocenti, E. AU - Freschi, M. AU - Jachetti, E. PY - 2008 DA - 2008// TI - Vasculature-targeted tumor necrosis factor-alpha increases the therapeutic index of doxorubicin against prostate cancer JO - Prostate VL - 68 UR - https://doi.org/10.1002/pros.20775 DO - 10.1002/pros.20775 ID - Bertilaccio2008 ER - TY - JOUR AU - Crescenzi, M. AU - Persano, L. AU - Esposito, G. AU - Zulato, E. AU - Borsi, L. AU - Balza, E. PY - 2011 DA - 2011// TI - Vandetanib improves anti-tumor effects of L19mTNFalpha in xenograft models of esophageal cancer JO - Clin Cancer Res VL - 17 UR - https://doi.org/10.1158/1078-0432.CCR-10-1420 DO - 10.1158/1078-0432.CCR-10-1420 ID - Crescenzi2011 ER - TY - JOUR AU - Gregorc, V. AU - Braud, F. G. AU - Pas, T. M. AU - Scalamogna, R. AU - Citterio, G. AU - Milani, A. PY - 2011 DA - 2011// TI - Phase I study of NGR-hTNF, a selective vascular targeting agent, in combination with cisplatin in refractory solid tumors JO - Clin Cancer Res VL - 17 UR - https://doi.org/10.1158/1078-0432.CCR-10-1376 DO - 10.1158/1078-0432.CCR-10-1376 ID - Gregorc2011 ER - TY - JOUR AU - Santoro, A. AU - Rimassa, L. AU - Sobrero, A. F. AU - Citterio, G. AU - Sclafani, F. AU - Carnaghi, C. PY - 2010 DA - 2010// TI - Phase II study of NGR-hTNF, a selective vascular targeting agent, in patients with metastatic colorectal cancer after failure of standard therapy JO - Eur J Cancer VL - 46 UR - https://doi.org/10.1016/j.ejca.2010.07.012 DO - 10.1016/j.ejca.2010.07.012 ID - Santoro2010 ER - TY - JOUR AU - Gregorc, V. AU - Santoro, A. AU - Bennicelli, E. AU - Punt, C. J. AU - Citterio, G. AU - Timmer-Bonte, J. N. PY - 2009 DA - 2009// TI - Phase Ib study of NGR-hTNF, a selective vascular targeting agent, administered at low doses in combination with doxorubicin to patients with advanced solid tumours JO - Br J Cancer VL - 101 UR - https://doi.org/10.1038/sj.bjc.6605162 DO - 10.1038/sj.bjc.6605162 ID - Gregorc2009 ER - TY - JOUR AU - Gregorc, V. AU - Zucali, P. A. AU - Santoro, A. AU - Ceresoli, G. L. AU - Citterio, G. AU - Pas, T. M. PY - 2010 DA - 2010// TI - Phase II study of asparagine-glycine-arginine-human tumor necrosis factor alpha, a selective vascular targeting agent, in previously treated patients with malignant pleural mesothelioma JO - J Clin Oncol VL - 28 UR - https://doi.org/10.1200/JCO.2009.27.3649 DO - 10.1200/JCO.2009.27.3649 ID - Gregorc2010 ER - TY - JOUR AU - Li, Z. J. AU - Wu, W. K. AU - Ng, S. S. AU - Yu, L. AU - Li, H. T. AU - Wong, C. C. PY - 2010 DA - 2010// TI - A novel peptide specifically targeting the vasculature of orthotopic colorectal cancer for imaging detection and drug delivery JO - J Control Release VL - 148 UR - https://doi.org/10.1016/j.jconrel.2010.09.015 DO - 10.1016/j.jconrel.2010.09.015 ID - Li2010 ER - TY - JOUR AU - Lu, L. AU - Li, Z. J. AU - Li, L. F. AU - Wu, W. K. AU - Shen, J. AU - Zhang, L. PY - 2015 DA - 2015// TI - Vascular-targeted TNFα improves tumor blood vessel function and enhances antitumor immunity and chemotherapy in colorectal cancer JO - J Control Release VL - 210 UR - https://doi.org/10.1016/j.jconrel.2015.05.282 DO - 10.1016/j.jconrel.2015.05.282 ID - Lu2015 ER - TY - JOUR AU - Zeytin, H. AU - Reali, E. AU - Zaharoff, D. A. AU - Rogers, C. J. AU - Schlom, J. AU - Greiner, J. W. PY - 2008 DA - 2008// TI - Targeted delivery of murine IFN-gamma using a recombinant fowlpox virus: NK cell recruitment to regional lymph nodes and priming of tumor-specific host immunity JO - J Interferon Cytokine Res VL - 28 UR - https://doi.org/10.1089/jir.2007.0063 DO - 10.1089/jir.2007.0063 ID - Zeytin2008 ER - TY - JOUR AU - Schroder, K. AU - Hertzog, P. J. AU - Ravasi, T. AU - Hume, D. A. PY - 2004 DA - 2004// TI - Interferon-gamma: an overview of signals, mechanisms and functions JO - J Leukoc Biol VL - 75 UR - https://doi.org/10.1189/jlb.0603252 DO - 10.1189/jlb.0603252 ID - Schroder2004 ER - TY - JOUR AU - Ebbinghaus, C. AU - Ronca, R. AU - Kaspar, M. AU - Grabulovski, D. AU - Berndt, A. AU - Kosmehl, H. PY - 2005 DA - 2005// TI - Engineered vascular-targeting antibody-interferon-gamma fusion protein for cancer therapy JO - Int J Cancer VL - 116 UR - https://doi.org/10.1002/ijc.20952 DO - 10.1002/ijc.20952 ID - Ebbinghaus2005 ER - TY - JOUR AU - Bansal, R. AU - Tomar, T. AU - Ostman, A. AU - Poelstra, K. AU - Prakash, J. PY - 2012 DA - 2012// TI - Selective targeting of interferon γ to stromal fibroblasts and pericytes as a novel therapeutic approach to inhibit angiogenesis and tumor growth JO - Mol Cancer Ther VL - 11 UR - https://doi.org/10.1158/1535-7163.MCT-11-0758 DO - 10.1158/1535-7163.MCT-11-0758 ID - Bansal2012 ER - TY - JOUR AU - Curnis, F. AU - Gasparri, A. AU - Sacchi, A. AU - Cattaneo, A. AU - Magni, F. AU - Corti, A. PY - 2005 DA - 2005// TI - Targeted delivery of IFNgamma to tumor vessels uncouples antitumor from counterregulatory mechanisms JO - Cancer Res VL - 65 UR - https://doi.org/10.1158/0008-5472.CAN-04-4282 DO - 10.1158/0008-5472.CAN-04-4282 ID - Curnis2005 ER - TY - JOUR AU - Kim, H. S. AU - Kim, S. AU - Lee, M. S. PY - 2005 DA - 2005// TI - IFN-gamma sensitizes MIN6N8 insulinoma cells to TNF-alpha-induced apoptosis by inhibiting NF-kappaB-mediated XIAP upregulation JO - Biochem Biophys Res Commun VL - 336 UR - https://doi.org/10.1016/j.bbrc.2005.08.183 DO - 10.1016/j.bbrc.2005.08.183 ID - Kim2005 ER - TY - JOUR AU - Bauer, S. AU - Oosterwijk-Wakka, J. C. AU - Adrian, N. AU - Oosterwijk, E. AU - Fischer, E. AU - Wuest, T. PY - 2009 DA - 2009// TI - Targeted therapy of renal cell carcinoma: synergistic activity of cG250-TNF and IFNg JO - Int J Cancer VL - 125 UR - https://doi.org/10.1002/ijc.24359 DO - 10.1002/ijc.24359 ID - Bauer2009 ER - TY - JOUR AU - Suk, K. AU - Chang, I. AU - Kim, Y. H. AU - Kim, S. AU - Kim, J. Y. AU - Kim, H. PY - 2001 DA - 2001// TI - Interferon gamma (IFNgamma) and tumor necrosis factor alpha synergism in ME-180 cervical cancer cell apoptosis and necrosis. IFNgamma inhibits cytoprotective NF-kappa B through STAT1/IRF-1 pathways JO - J Biol Chem VL - 276 UR - https://doi.org/10.1074/jbc.M007646200 DO - 10.1074/jbc.M007646200 ID - Suk2001 ER - TY - JOUR AU - Fransen, L. AU - Heyden, J. AU - Ruysschaert, R. AU - Fiers, W. PY - 1986 DA - 1986// TI - Recombinant tumor necrosis factor: its effect and its synergism with interferon-gamma on a variety of normal and transformed human cell lines JO - Eur J Cancer Clin Oncol VL - 22 UR - https://doi.org/10.1016/0277-5379(86)90107-0 DO - 10.1016/0277-5379(86)90107-0 ID - Fransen1986 ER - TY - JOUR AU - Fiedler, W. AU - Zeller, W. AU - Peimann, C. J. AU - Weh, H. J. AU - Hossfeld, D. K. PY - 1991 DA - 1991// TI - A phase II combination trial with recombinant human tumor necrosis factor and gamma interferon in patients with colorectal cancer JO - Klin Wochenschr VL - 69 UR - https://doi.org/10.1007/BF01666852 DO - 10.1007/BF01666852 ID - Fiedler1991 ER - TY - JOUR AU - Demetri, G. D. AU - Spriggs, D. R. AU - Sherman, M. L. AU - Arthur, K. A. AU - Imamura, K. AU - Kufe, D. W. PY - 1989 DA - 1989// TI - A phase I trial of recombinant human tumor necrosis factor and interferon-gamma: effects of combination cytokine administration in vivo JO - J Clin Oncol VL - 7 ID - Demetri1989 ER - TY - JOUR AU - Abbruzzese, J. L. AU - Levin, B. AU - Ajani, J. A. AU - Faintuch, J. S. AU - Pazdur, R. AU - Saks, S. PY - 1990 DA - 1990// TI - A phase II trial of recombinant human interferon-gamma and recombinant tumor necrosis factor in patients with advanced gastrointestinal malignancies: results of a trial terminated by excessive toxicity JO - J Biol Response Mod VL - 9 ID - Abbruzzese1990 ER - TY - JOUR AU - Abbruzzese, J. L. AU - Levin, B. AU - Ajani, J. A. AU - Faintuch, J. S. AU - Saks, S. AU - Patt, Y. Z. PY - 1989 DA - 1989// TI - Phase I trial of recombinant human gamma-interferon and recombinant human tumor necrosis factor in patients with advanced gastrointestinal cancer JO - Cancer Res VL - 49 ID - Abbruzzese1989 ER - TY - JOUR AU - Zhou, F. PY - 2009 DA - 2009// TI - Molecular mechanisms of IFN-gamma to up-regulate MHC class I antigen processing and presentation JO - Int Rev Immunol VL - 28 UR - https://doi.org/10.1080/08830180902978120 DO - 10.1080/08830180902978120 ID - Zhou2009 ER - TY - JOUR AU - Hui, X. AU - Han, Y. AU - Liang, S. AU - Liu, Z. AU - Liu, J. AU - Hong, L. PY - 2008 DA - 2008// TI - Specific targeting of the vasculature of gastric cancer by a new tumor-homing peptide CGNSNPKSC JO - J Control Release VL - 131 UR - https://doi.org/10.1016/j.jconrel.2008.07.024 DO - 10.1016/j.jconrel.2008.07.024 ID - Hui2008 ER - TY - JOUR AU - Firer, M. A. AU - Gellerman, G. PY - 2012 DA - 2012// TI - Targeted drug delivery for cancer therapy: the other side of antibodies JO - J Hematol Oncol VL - 5 UR - https://doi.org/10.1186/1756-8722-5-70 DO - 10.1186/1756-8722-5-70 ID - Firer2012 ER - TY - JOUR AU - D’Onofrio, N. AU - Caraglia, M. AU - Grimaldi, A. AU - Marfella, R. AU - Servillo, L. AU - Paolisso, G. PY - 2014 DA - 2014// TI - Vascular-homing peptides for targeted drug delivery and molecular imaging: meeting the clinical challenges JO - Biochim Biophys Acta VL - 1846 ID - D’Onofrio2014 ER - TY - JOUR AU - Sugarman, B. J. AU - Aggarwal, B. B. AU - Hass, P. E. AU - Figari, I. S. AU - Palladino, M. A. AU - Shepard, H. M. PY - 1985 DA - 1985// TI - Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro JO - Science VL - 230 UR - https://doi.org/10.1126/science.3933111 DO - 10.1126/science.3933111 ID - Sugarman1985 ER - TY - JOUR AU - Ohmori, Y. AU - Hamilton, T. A. PY - 1995 DA - 1995// TI - The interferon-stimulated response element and a kappa B site mediate synergistic induction of murine IP-10 gene transcription by IFN-gamma and TNF-alpha JO - J Immunol VL - 154 ID - Ohmori1995 ER - TY - JOUR AU - Jahnke, A. AU - Johnson, J. P. PY - 1994 DA - 1994// TI - Synergistic activation of intercellular adhesion molecule 1 (ICAM-1) by TNF-alpha and IFN-gamma is mediated by p65/p50 and p65/c-Rel and interferon-responsive factor Stat1 alpha (p91) that can be activated by both IFN-gamma and IFN-alpha JO - FEBS Lett VL - 354 UR - https://doi.org/10.1016/0014-5793(94)01130-3 DO - 10.1016/0014-5793(94)01130-3 ID - Jahnke1994 ER - TY - JOUR AU - Shah, P. AU - Meide, P. H. AU - Borman, T. AU - Schroeder, N. AU - Bliss, J. M. AU - Coombes, R. C. PY - 1989 DA - 1989// TI - Effect of human recombinant tumour necrosis factor and rat gamma interferon on nitrosomethylurea-induced mammary tumours JO - Br J Cancer VL - 59 UR - https://doi.org/10.1038/bjc.1989.42 DO - 10.1038/bjc.1989.42 ID - Shah1989 ER - TY - JOUR AU - Johansson, A. AU - Hamzah, J. AU - Payne, C. J. AU - Ganss, R. PY - 2012 DA - 2012// TI - Tumor-targeted TNFalpha stabilizes tumor vessels and enhances active immunotherapy JO - Proc Natl Acad Sci USA VL - 109 UR - https://doi.org/10.1073/pnas.1118296109 DO - 10.1073/pnas.1118296109 ID - Johansson2012 ER - TY - JOUR AU - Antwerp, D. J. AU - Martin, S. J. AU - Kafri, T. AU - Green, D. R. AU - Verma, I. M. PY - 1996 DA - 1996// TI - Suppression of TNF-alpha-induced apoptosis by NF-kappaB JO - Science VL - 274 UR - https://doi.org/10.1126/science.274.5288.787 DO - 10.1126/science.274.5288.787 ID - Antwerp1996 ER - TY - JOUR AU - Antwerp, D. J. AU - Martin, S. J. AU - Verma, I. M. AU - Green, D. R. PY - 1998 DA - 1998// TI - Inhibition of TNF-induced apoptosis by NF-kappa B JO - Trends Cell Biol VL - 8 UR - https://doi.org/10.1016/S0962-8924(97)01215-4 DO - 10.1016/S0962-8924(97)01215-4 ID - Antwerp1998 ER - TY - JOUR AU - Kost, E. R. AU - Mutch, D. G. AU - Herzog, T. J. PY - 1999 DA - 1999// TI - Interferon-gamma and tumor necrosis factor-alpha induce synergistic cytolytic effects in ovarian cancer cell lines-roles of the TR60 and TR80 tumor necrosis factor receptors JO - Gynecol Oncol VL - 72 UR - https://doi.org/10.1006/gyno.1998.5257 DO - 10.1006/gyno.1998.5257 ID - Kost1999 ER - TY - JOUR AU - Pandita, R. AU - Pocsik, E. AU - Aggarwal, B. B. PY - 1992 DA - 1992// TI - Interferon-gamma induces cell surface expression for both types of tumor necrosis factor receptors JO - FEBS Lett VL - 312 UR - https://doi.org/10.1016/0014-5793(92)81416-J DO - 10.1016/0014-5793(92)81416-J ID - Pandita1992 ER -